FDA OKs MitraClip for inoperable patients

Candace Stuart | | Cardiovascular Business | Structural Heart Disease

The FDA approved the MitraClip as a treatment for patients with mitral regurgitation who are considered too high risk for mitral valve surgery.

The MitraClip is a minimally invasive device that is catheter based, making it a potentially suitable treatment for patients with significant symptomatic mitral regurgitation who may be too sick or frail to undergo open heart surgery. The device is delivered transfemorally to the heart and then implanted.   

The FDA’s Circulatory System Devices Panel voted 5-3 in favor of Abbott’s MitraClip clip delivery system on March 20. Their recommendation was based on results from three trials: EVEREST II (Endovascular Valve Edge-to-Edge Repair Study), EVEREST II High Risk and REALISM (Real World ExpAnded MuLtIcenter Study of the MitraClip System), which evaluated MitraClip therapy in high surgical risk patients with significant mitral regurgitation.

The MitraClip device received CE Mark in 2008 and is commercially available in Europe and other international markets. Abbott Park, Ill.-based Abbott announced the U.S. launch of the MitraClip in conjunction with the FDA’s approval. 

Candace Stuart, Contributor

Related Content

How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
9 key takeaways from AHA 2024 in Chicago
Redo TAVR: The impact of implanting balloon-expandable valves in failed self-expanding valves
Edoxaban could limit blood clots, ‘make life easier’ for heart valve surgery patients

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."